Stock NAMS NEWAMSTERDAM PHARMA COMPANY N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Static Chart NewAmsterdam Pharma Company N.V. Nasdaq

Equities

NAMS

NL00150012L7

Real-time Estimate Cboe BZX
Other stock markets
 10:53:01 2024-07-12 am EDT 		5-day change 1st Jan Change
19.89 USD -5.24% Intraday chart for NewAmsterdam Pharma Company N.V. +4.95% +87.91%
Jul. 08 NewAmsterdam Pharma Completes Enrollment for Phase 3 Trial of Potential Cardiovascular Disease Treatment MT
Jul. 08 NewAmsterdam Pharma Completes Enrollment in Pivotal Phase 3 TANDEM Clinical Trial Evaluating Fixed-Dose Combination of Obicetrapib plus Ezetimibe in Patients with HeFH and/or ASCVD or ASCVD Risk Factors CI
Chart NewAmsterdam Pharma Company N.V.
  1. Stock Market
  2. Equities
  3. NAMS Stock
  4. NAMS Stock
  5. Charts NewAmsterdam Pharma Company N.V.
  6. Static Chart